XML 13 R5.htm IDEA: XBRL DOCUMENT v3.22.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDER'S DEFICIT - USD ($)
Series B Convertible Preferred Stock [Member]
Series C Convertible Preferred Stock [Member]
Series H Convertible Preferred Stock [Member]
Common Stock [Member]
Treasury Stock [Member]
Stock Loan Receivable [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 51 $ (1,286,118) $ (15,220,294) $ 251,046,191 $ (270,651,339) $ (27,858,303)
Beginning balance, shares at Dec. 31, 2020 45,000 700 20,000 5,133,489 2,080        
Common stock issued for conversion of convertible debt and accrued interest $ 45 3,122,803 3,122,848
Common stock issued for conversion of convertible debt and accrued interest, shares       4,483,717          
Common stock issued for services $ 2 281,748 281,750
Common stock issued for services , shares       245,000          
Fair value of beneficial conversion feature of converted 9,207,107 9,207,107
Net loss (5,375,609) (5,375,609)
Ending balance, value at Mar. 31, 2021 $ 98 $ (1,286,118) (15,220,294) 263,657,849 (276,026,948) (20,622,207)
Ending balance, shares at Mar. 31, 2021 45,000 700 20,000 9,862,206 2,080        
Common stock issued for conversion of convertible debt and accrued interest $ 7 592,698 592,705
Common stock issued for conversion of convertible debt and accrued interest, shares       720,311          
Common stock issued for joint venture $ 140 15,399,860 15,400,000
Common stock issued for joint venture ,shares       14,000,000          
Fair value of beneficial conversion feature of converted 522,349 522,349
Net loss (27,048,655) (27,048,655)
Ending balance, value at Jun. 30, 2021 $ 245 $ (1,286,118) (15,220,294) 280,172,756 (303,075,603) (31,155,808)
Ending balance, shares at Jun. 30, 2021 45,000 700 20,000 24,582,517 2,080        
Beginning balance, value at Dec. 31, 2021 $ 332 $ (643,059) (7,610,147) 284,072,666 (304,581,773) (28,761,981)
Beginning balance, shares at Dec. 31, 2021 45,000 700 20,000 33,200,198 1,040        
Common stock issued for conversion of convertible debt and accrued interest $ 4 34,996 35,000
Common stock issued for conversion of convertible debt and accrued interest, shares       369,198          
Fair value of beneficial conversion feature of converted 49,504 49,504
Common stock issued for cash $ 4 68,304 68,308
Common stock issued for cash , shares       463,303          
Net loss 3,926,239 3,926,239
Ending balance, value at Mar. 31, 2022 $ 340 $ (643,059) (7,610,147) 284,225,470 (300,655,534) (24,682,930)
Ending balance, shares at Mar. 31, 2022 45,000 700 20,000 34,032,699 1,040        
Beginning balance, value at Dec. 31, 2021 $ 332 $ (643,059) (7,610,147) 284,072,666 (304,581,773) (28,761,981)
Beginning balance, shares at Dec. 31, 2021 45,000 700 20,000 33,200,198 1,040        
Ending balance, value at Jun. 30, 2022 $ 9,777 $ (643,059) (7,610,147) 287,617,690 (304,096,671) (24,722,409)
Ending balance, shares at Jun. 30, 2022 45,000 700 20,000 977,741,469 1,040        
Beginning balance, value at Mar. 31, 2022 $ 340 $ (643,059) (7,610,147) 284,225,470 (300,655,534) (24,682,930)
Beginning balance, shares at Mar. 31, 2022 45,000 700 20,000 34,032,699 1,040        
Common stock issued for conversions $ 2,887 1,663,973 1,666,861
Common stock issued for conversions ,shares       288,672,073          
Fair value of derivative liability due to conversions 1,571,238 1,571,238
Common stock issued for cash $ 50 163,508 163,559
Common stock issued for cash , shares       5,036,697          
Common stock issued for JV - Tokenize $ 1,500 (1,500)
Common stock issued for JV - Tokenize ,shares       150,000,000          
Common stock issued for JV - Meta $ 5,000 (5,000)
Common stock issued for JV - Meta ,shares       500,000,000          
Net loss (3,441,137) (3,441,137)
Ending balance, value at Jun. 30, 2022 $ 9,777 $ (643,059) $ (7,610,147) $ 287,617,690 $ (304,096,671) $ (24,722,409)
Ending balance, shares at Jun. 30, 2022 45,000 700 20,000 977,741,469 1,040